XML 72 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHARE CAPITAL, WARRANTS AND OPTIONS (Details Narrative)
 3 Months Ended 6 Months Ended 12 Months Ended
Apr. 28, 2022
CAD ($)
$ / shares
shares
Apr. 08, 2022
CAD ($)
Apr. 02, 2022
CAD ($)
$ / shares
Apr. 20, 2021
CAD ($)
$ / shares
shares
Jun. 30, 2022
CAD ($)
$ / shares
shares
Jun. 30, 2021
CAD ($)
$ / shares
shares
Jun. 30, 2022
CAD ($)
shares
$ / shares
Jun. 30, 2021
CAD ($)
shares
$ / shares
Dec. 31, 2021
CAD ($)
shares
$ / shares
Dec. 31, 2020
shares
IfrsStatementLineItems [Line Items]                    
Number of shares issued         2,665,404   2,665,404      
Proceeds from exercise of warrants | $                 $ 12,580,314  
Number of warrants exercised             9,186,012      
Share capital issued through exercise of warrants                 13,080,314  
Proceeds from private placements | $ $ 10,136,640 $ 10,000,320 $ 5,000,000 $ 1,989,760            
Par value per share | $ / shares $ 0.48   $ 0.48 $ 0.24            
Issuance of subscription receipts units 21,118,000                  
Proceeds from exercise of warrants and options | $             $ 380,000 $ 670,000    
Proceeds from exercise of options | $                 $ 112,000  
Number of stock option exercised                 500,000 0
Warrants exercised                   0
Issuance of private placement units       8,290,665            
Expected dividend as percentage, share options granted             0.00%    
Risk free interest rate, share options granted             0.93%    
Expected volatility, share options granted             127.83%    
Exercise price of warrant | $ / shares         $ 9.00   $ 9.00      
Share based payment expense | $         $ 837,000    
Increase (Decrease) through expiry of options and warrants, equity | $             61,676 97,953    
Share capital for exercised warrants options | $             138,662 244,357    
Share-based payments | $             $ 0 $ 837,444    
Incentive Stock Options [Member]                    
IfrsStatementLineItems [Line Items]                    
Number of stock option granted             0      
Stock Option Plan [Member]                    
IfrsStatementLineItems [Line Items]                    
Period of options granted               5 years 5 years  
Number of stock option granted               3,185,000 8,178,972  
Stock options exercisable price per share | $ / shares           $ 0.32   $ 0.32    
Share based payment expense | $               $ 837,444 $ 2,530,706  
Weighted average fair value of options granted | $ / shares                 $ 0.31  
Stock Option Plan [Member] | Options One [Member]                    
IfrsStatementLineItems [Line Items]                    
Number of stock option exercised                 3,185,000  
Stock options exercisable price per share | $ / shares                 $ 0.32  
Stock Option Plan [Member] | Options Two [Member]                    
IfrsStatementLineItems [Line Items]                    
Number of stock option exercised                 4,993,972  
Stock options exercisable price per share | $ / shares                 $ 0.40  
Top of range [member]                    
IfrsStatementLineItems [Line Items]                    
Percentage of beneficially owns, issued and outstanding             10.00%      
Period of options granted             10 years      
Private Placements [Member]                    
IfrsStatementLineItems [Line Items]                    
Fair value of warrants issued | $         464,493   $ 464,493      
Agents [Member]                    
IfrsStatementLineItems [Line Items]                    
Fair value of warrants issued | $         $ 30,735   $ 30,735      
Non Brokered Private Placement [Member]                    
IfrsStatementLineItems [Line Items]                    
Expected life             1 year 6 months      
Expected dividend as percentage, share options granted             0.00%      
Risk free interest rate, share options granted             0.29%      
Expected volatility, share options granted             132.00%      
Ordinary shares [member]                    
IfrsStatementLineItems [Line Items]                    
Number of shares issued         133,870,031 124,449,332 133,870,031 124,449,332 131,204,627 109,833,648
Proceeds from exercise of warrants | $             $ 379,563 $ 669,547    
Number of warrants exercised             2,665,404 6,325,019    
Share capital issued through exercise of warrants             2,665,404 6,325,019    
Number of shares outstanding         133,870,031 124,449,332 133,870,031 124,449,332 131,204,627 109,833,648
Proceeds from exercise of warrants and options | $                 $ 1,641,675  
Share based payment expense | $                
Warrants [Member]                    
IfrsStatementLineItems [Line Items]                    
Warrants description       Each unit consists of one common share in the capital of the Company and one half transferable common share purchase warrant (“Warrant”) of the Company. Each full Warrant entitles the holder to acquire one common share of the Company within twenty-four (24) months following its issuance date, at a price of $0.35. The warrants are subject to an acceleration clause such that if the closing market price of the common shares on the TSX-V is greater than $0.60 per common share for a period of 10 consecutive trading days at any time after the four-month anniversary of the closing of the placement, the Company may, at its option, accelerate the warrant expiry date to within 30 days            
Finder Warrants [Member]                    
IfrsStatementLineItems [Line Items]                    
Warrants description       the Company has paid eligible finders (the “Finders”): (i) cash commission equal to 6% of the gross proceeds raised from subscribers introduced to the Company by such Finders, being an aggregate of $65,830, and (ii) a number of common share purchase warrants (the “Finder Warrants”) equal to 6% of the units attributable to the Finders under the private placement, being an aggregate of 274,289 Finder Warrants. Each Finder Warrant entitles the Finder to acquire one common share of the Company for a period of twenty-four (24) months following its issuance date, at an exercise price of $0.35            
Series 1 Convertible Preferred Shares [Member]                    
IfrsStatementLineItems [Line Items]                    
Authorized capital         100,000,000   100,000,000      
Series 1 Preferred Shares [Member]                    
IfrsStatementLineItems [Line Items]                    
Number of shares outstanding         590,931 590,931 590,931 590,931